Additionally, we functionally characterized the effects of this mutation on FOXL2 activity, experimentally validating the relevance of this mutation to the pathogenesis of BPES. This evidence concerns the gene FOXL2 and blepharophimosis, ptosis, and epicanthus inversus syndrome.